J. Wolff, R. Malone, P. Williams, W. Chong, G. Acsadi et al., Direct gene transfer into mouse muscle in vivo, Science, vol.247, issue.4949, pp.1465-1473, 1990.
DOI : 10.1126/science.1690918

D. Tang, M. Devit, and S. Johnson, Genetic immunization is a simple method for eliciting an 452 immune response, Nature, vol.3563, pp.152-156, 1992.

G. Cox, T. Zamb, and L. Babiuk, Bovine herpesvirus 1: immune response in mice and cattle 454 injected with plasmid DNA, J Virol, vol.67, issue.4, pp.5664-5671, 1993.

J. Ulmer, J. Donnelly, S. Parker, G. Rhodes, P. Felgner et al., Heterologous 456 protection against influenza by injection of DNA encoding a viral protein, Science, vol.2595, pp.1745-1754, 1993.

S. Gurunathan, D. Klinman, and R. Seder, DNA Vaccines: Immunology, Application, and Optimization, Annual Review of Immunology, vol.18, issue.1, pp.927-74, 2000.
DOI : 10.1146/annurev.immunol.18.1.927

D. Feltquate, . Dna, A. Valera, J. Perales, M. Hatzoglou et al., Vector design, delivery, and antigen presentation, J Cell Biochem, vol.3031, issue.461, pp.304-315, 1998.
DOI : 10.1002/(sici)1097-4644(1998)72:30/31+<304::aid-jcb37>3.0.co;2-w

J. Hartikka, M. Sawdey, F. Cornefert-jensen, M. Margalith, K. Barnhart et al., An 464 improved plasmid DNA expression vector for direct injection into skeletal muscle, Hum Gene Ther, vol.4657, issue.9, pp.1205-1222, 1996.

Y. Sato, M. Roman, H. Tighe, D. Lee, M. Corr et al., Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization, Science, vol.273, issue.5273, pp.352-356, 1996.
DOI : 10.1126/science.273.5273.352

B. Spies, H. Hochrein, M. Vabulas, K. Huster, D. Busch et al., Vaccination with 472 plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient 473 mice, J Immunol, vol.1117112, pp.4715908-4715920, 2003.

D. Stetson and R. Medzhitov, Recognition of Cytosolic DNA Activates an IRF3-Dependent Innate Immune Response, Immunity, vol.24, issue.1, pp.93-103, 2006.
DOI : 10.1016/j.immuni.2005.12.003

K. Peters, H. Smith, G. Stark, and G. Sen, IRF-3-dependent, NFkappa B-and JNK- 479 independent activation of the 561 and IFN-beta genes in response to double-stranded RNA, Proc Natl, p.480

H. Shirota, L. Petrenko, T. Hattori, and D. Klinman, Contribution of IRF-3 mediated IFNbeta 482 production to DNA vaccine dependent cellular immune responses, Vaccine, vol.2716, pp.2144-2153, 2009.

J. Mairhofer, I. Pfaffenzeller, D. Merz, and R. Grabherr, A novel antibiotic free plasmid selection system: Advances in safe and efficient DNA therapy, Biotechnology Journal, vol.99, issue.1, pp.83-92, 2008.
DOI : 10.1002/biot.200700141

H. Garmory, M. Leckenby, K. Griffin, S. Elvin, R. Taylor et al., Antibiotic-Free Plasmid Stabilization by Operator-Repressor Titration for Vaccine Delivery by Using Live Salmonella enterica Serovar Typhimurium, Infection and Immunity, vol.73, issue.4, pp.2005-2016, 2005.
DOI : 10.1128/IAI.73.4.2005-2011.2005

T. Hanke and A. Mcmichael, Design and construction of an experimental HIV-1 vaccine for a 494 year-2000 clinical trial in Kenya, Nat Med, vol.621, pp.951-956, 2000.

T. Hanke, A. Mcmichael, R. Samuel, L. Powell, L. Mcloughlin et al., Lack of 496 toxicity and persistence in the mouse associated with administration of candidate DNA-and modified 497 vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya A new DNA vehicle for nonviral 499 gene delivery: supercoiled minicircle Minicircle: an 501 improved DNA molecule for in vitro and in vivo gene transfer An araC- 503 controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and 504 mitochondrial gene therapy, Vaccine Gene Therapy Gene Therapy Bigger BW Journal of Biological Chemistry, vol.212242362427625, issue.502, pp.108-122, 1997.

P. Mayrhofer, M. Blaesen, M. Schleef, and W. Jechlinger, Minicircle-DNA production by site 506 specific recombination and protein-DNA interaction chromatography, J Gene Med, vol.1026, pp.1253-69, 2008.
DOI : 10.1002/jgm.1243

M. Molnar, R. Gilbert, Y. Lu, A. Liu, A. Guo et al., Factors influencing the 508 efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse 509 muscles, Mol Ther, vol.1027, pp.447-55, 2004.

X. Zhang, M. Epperly, M. Kay, Z. Chen, T. Dixon et al., Radioprotection in 514 vitro and in vivo by minicircle plasmid carrying the human manganese superoxide dismutase 515 transgene, Hum Gene Ther, vol.1929, pp.820-826, 2008.

K. Hirata, M. Nishikawa, N. Kobayashi, Y. Takahashi, and Y. Takakura, Design of PCR-amplified 517 DNA fragments for in vivo gene delivery: size-dependency on stability and transgene expression, p.518

R. Schirmbeck, S. Konig-merediz, P. Riedl, M. Kwissa, F. Sack et al., Priming of 523 immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified 524 with a nuclear localization signal peptide, J Mol Med, vol.7932, pp.522343-50, 2001.

C. Zheng, C. Juhls, D. Oswald, F. Sack, I. Westfehling et al., Effect of different nuclear 526 localization sequences on the immune responses induced by a MIDGE vector encoding bovine 527 herpesvirus-1 glycoprotein D, Vaccine, vol.2433, pp.4625-4634, 2006.

S. Moreno, L. Lopez-fuertes, A. Vila-coro, F. Sack, C. Smith et al., DNA 529 immunisation with minimalistic expression constructs, Vaccine, vol.2234, pp.1709-1725, 2004.

L. Lopez-fuertes, E. Perez-jimenez, A. Vila-coro, F. Sack, S. Moreno et al., DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice, Vaccine, vol.21, issue.3-4, pp.247-57, 2002.
DOI : 10.1016/S0264-410X(02)00450-4

C. Leutenegger, F. Boretti, C. Mislin, J. Flynn, M. Schroff et al., Immunization 534 of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic 535 defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL- 536 12), IL-16, or a CpG motif, J Virol, vol.357436, pp.53310447-57, 2000.

Y. Choi, Y. Jeon, J. Kang, J. Chung, M. Schmidt et al., MIDGE/hNIS vaccination 538 generates antigen-associated CD8+IFN-gamma+ T cells and enhances protective antitumor immunity

M. Bacaestrada, M. Foldvari, S. Babiuk, and L. Babiuk, Vaccine delivery: lipid-based delivery [38] Lundstrom K. Alphavirus vectors: Applications for DNA vaccine production and gene 543 expression, Int J Cancer Intervirology, vol.1203743, issue.540, pp.1942-50247, 2000.

N. Mielcarek, S. Alonso, C. Locht, J. Sin, M. Bagarazzi et al., Nasal vaccination using live bacterial vectors, Advanced Drug Delivery Reviews, vol.51, issue.1-3, pp.55-69, 2001.
DOI : 10.1016/S0169-409X(01)00168-5

M. Barry, D. Pinto-gonzalez, F. Orson, G. Mckenzie, G. Petry et al., Role of 553 endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after 554 naked DNA injection, DNA and Cell Biology Hum Gene Ther, vol.18421043, issue.552, pp.771-92461, 1999.

G. Widera, M. Austin, D. Rabussay, C. Goldbeck, S. Barnett et al., Increased DNA 556 vaccine delivery and immunogenicity by electroporation in vivo, Journal of Immunology, vol.55716444, pp.4635-4675, 2000.

J. Scheerlinck, J. Karlis, T. Tjelle, P. Presidente, I. Mathiesen et al., In vivo electroporation improves immune responses to DNA vaccination in sheep, Vaccine, vol.22, issue.13-14, pp.1820-1825, 2004.
DOI : 10.1016/j.vaccine.2003.09.053

C. Wu, S. Lee, H. Huang, M. Tao, R. Sheets et al., In vivo electroporation of skeletal muscles increases 561 the efficacy of Japanese encephalitis virus DNA vaccine Biodistribution of DNA 563 plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is 564 similar, without integration, despite differing plasmid backbones or gene inserts, Vaccine Toxicol Sci, vol.229147, issue.565, pp.1457-64, 2004.

M. Barry and S. Johnston, Biological features of genetic immunization, Vaccine, vol.15, issue.8, pp.788-567, 1997.
DOI : 10.1016/S0264-410X(96)00265-4

S. Ren, M. Li, J. Smith, L. Detolla, and P. Furth, Low-volume jet injection for intradermal 569 immunization in rabbits, BMC Biotechnol, vol.249, pp.10-570, 2002.

A. Choi, K. Smiley, M. Basu, M. Mcneal, M. Shao et al., Protection of mice 571 against rotavirus challenge following intradermal DNA immunization by Biojector needle-free 572 injection, Vaccine, vol.2550, pp.3215-3223, 2007.

M. Kang, C. Kim, M. Kim, T. Hwang, S. Kang et al., Skin permeation, 574 biodistribution, and expression of topically applied plasmid DNA 576 Optimization of intradermal vaccination by DNA tattooing in human skin Immunization via hair follicules by topical 578 application of naked DNA to normal skin, J Gene Med Hum Gene Ther Nature Biotechnology, vol.65217, issue.577, pp.1238-46870, 1999.

J. Boyle, A. Silva, J. Brady, and A. Lew, DNA immunization: induction of higher avidity 580

U. Hahn, A. M. Czerny, C. Bohm, R. Beyer, and W. , Protection of mice against challenge with 582

W. Zhu, C. Thomas, and P. Sparling, DNA immunization of mice with a plasmid encoding 584

D. Pokorna, I. Rubio, and M. Muller, DNA-vaccination via tattooing induces stronger humoral and 587 cellular immune responses than intramuscular delivery supported by molecular adjuvants, Genet Vaccines Ther, vol.5886, pp.4-57, 2008.

T. Pertmer, T. Roberts, and J. Haynes, Influenza virus nucleoprotein-specific immunoglobulin 590

W. Bohm, T. Mertens, R. Schirmbeck, and J. Reimann, Routes of plasmid DNA vaccination that 595 prime murine humoral and cellular immune responses, Vaccine, vol.1660, pp.949-54, 1998.

S. Rao, W. Kong, C. Wei, Z. Yang, M. Nason et al., Multivalent HA DNA 597 vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice

N. Etchart, R. Buckland, M. Liu, T. Wild, and D. Kaiserlian, Class I-restricted CTL induction by 600 mucosal immunization with naked DNA encoding measles virus haemagglutinin, J Gen Virol, vol.6017862, pp.1577-80, 1997.

R. Jia, J. Guo, M. Fan, Z. Bian, Z. Chen et al., Mucosal immunization against dental 603 caries with plasmid DNA encoding pac gene of Streptococcus mutans in rats, Vaccine, vol.2263, pp.2511-604, 2004.

M. Daheshia, N. Kuklin, E. Manickan, S. Chun, and B. Rouse, Immune induction and modulation 606 by topical ocular administration of plasmid DNA encoding antigens and cytokines, Vaccine, vol.6071664, pp.1103-1113, 1998.

T. Kanazawa, Y. Takashima, S. Hirayama, and H. Okada, Effects of menstrual cycle on gene 609 transfection through mouse vagina for DNA vaccine, Int J Pharm, vol.36065, pp.164-70, 2008.

J. Wolff, J. Ludtke, G. Acsadi, P. Williams, and J. A. , Long-term persistence of plasmid DNA 611 and foreign gene expression in mouse muscle, Hum Mol Genet, vol.166, pp.363-372, 1992.

V. Budker, T. Budker, G. Zhang, V. Subbotin, A. Loomis et al., Hypothesis: naked plasmid 613 DNA is taken up by cells in vivo by a receptor-mediated process Uptake and gene 615 expression of naked plasmid DNA in cultured brain microvessel endothelial cells, J Gene Med Biochem Biophys, vol.2, pp.76-88, 2000.

M. Levy, L. Barron, K. Meyer, S. Jr, and F. , Characterization of plasmid DNA transfer 618 into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene 619 products into blood, Gene Therapy, vol.3, pp.617201-617212, 1996.

M. Lehmann and G. Sczakiel, Spontaneous uptake of biologically active recombinant DNA by 621 mammalian cells via a selected DNA segment, Gene Ther, vol.1270, pp.446-51, 2005.

M. Wheeler, X. Cortez-gonzalez, R. Frazzi, and M. Zanetti, Ex vivo programming of antigen- 623 presenting B lymphocytes: considerations on DNA uptake and cell activation, Int Rev Immunol, vol.6242571, pp.83-97, 2006.

K. Luby-phelps, Cytoarchitecture and Physical Properties of Cytoplasm: Volume, Viscosity, Diffusion, Intracellular Surface Area, Int Rev Cytol, vol.19272, pp.189-221, 2000.
DOI : 10.1016/S0074-7696(08)60527-6

E. Vaughan and D. Dean, Intracellular trafficking of plasmids during transfection is mediated 628 by microtubules, Mol Ther, vol.1373, pp.422-430, 2006.

E. Vaughan, R. Geiger, A. Miller, P. Loh-marley, T. Suzuki et al., Microtubule 630 acetylation through HDAC6 inhibition results in increased transfection efficiency, Mol Ther, vol.6311674, pp.1841-1848, 2008.

A. Trombone, C. Silva, K. Lima, C. Oliver, M. Jamur et al., Endocytosis of 633 DNA-Hsp65 alters the pH of the late endosome/lysosome and interferes with antigen presentation

D. Lechardeur, A. Verkman, and G. Lukacs, Intracellular routing of plasmid DNA during non- 639 viral gene transfer, Adv Drug Deliv Rev, vol.5777, pp.755-67, 2005.

D. Lechardeur, K. Sohn, M. Haardt, P. Joshi, M. Monck et al., Metabolic 641 instability of plasmid DNA in the cytosol: a potential barrier to gene transfer, Gene Ther, vol.678, pp.482-642, 1999.

D. Lechardeur and G. Lukacs, Nucleocytoplasmic Transport of Plasmid DNA: A Perilous Journey from the Cytoplasm to the Nucleus, Human Gene Therapy, vol.0, issue.0, pp.882-891, 2006.
DOI : 10.1089/hum.2006.17.ft-238

J. Ludtke, M. Sebestyen, and J. Wolff, The effect of cell division on the cellular dynamics of 646 microinjected DNA and dextran, Mol Ther, vol.580, pp.579-88, 2002.

E. Hebert, Improvement of exogenous DNA nuclear importation by nuclear localization signal- 648 bearing vectors: a promising way for non-viral gene therapy?, Biol Cell, vol.9581, pp.59-68, 2003.

D. Dean, Import of Plasmid DNA into the Nucleus Is Sequence Specific, Experimental Cell Research, vol.230, issue.2, pp.293-302, 1997.
DOI : 10.1006/excr.1996.3427

D. Dean, B. Dean, S. Muller, and L. Smith, Sequence Requirements for Plasmid Nuclear Import, Experimental Cell Research, vol.253, issue.2
DOI : 10.1006/excr.1999.4716

A. Miller and D. Dean, Tissue-specific and transcription factor-mediated nuclear entry of 654 DNA, Adv Drug Deliv Rev, vol.6184, pp.653603-653616, 2009.

R. Hohlfeld and A. Engel, The immunobiology of muscle, Immunology Today, vol.15, issue.6, pp.269-74, 1994.
DOI : 10.1016/0167-5699(94)90006-X

M. Dupuis, K. Denismize, C. Woo, C. Goldbeck, M. Selby et al., Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice, The Journal of Immunology, vol.165, issue.5, pp.2850-2858, 2000.
DOI : 10.4049/jimmunol.165.5.2850

S. Fang, T. Nishimura, and K. Takahashi, Relationship between development of intramuscular 660 connective tissue and toughness of pork during growth of pigs Pimorady-Esfahani A, Grounds MD, McMenamin PG. Macrophages and dendritic cells in 662 normal and regenerating murine skeletal muscle, J Anim Sci Muscle Nerve, vol.77872088, pp.659120-659150, 1997.

I. Mclennan, Degenerating and regenerating skeletal muscles contain several subpopulations 664 of macrophages with distinct spatial and temporal distributions, J Anat, vol.18889, pp.17-28, 1996.

H. Honda, H. Kimura, and A. Rostami, Demonstration and phenotypic characterization of resident 666 macrophages in rat skeletal muscle, Immunology, vol.7090, pp.272-279, 1990.

E. Gronevik, S. Tollefsen, L. Sikkeland, T. Haug, T. Tjelle et al., DNA transfection of mononuclear cells in muscle tissue, The Journal of Gene Medicine, vol.352, issue.10, pp.909-926, 2003.
DOI : 10.1002/jgm.416

M. Chattergoon, T. Robinson, J. Boyer, and D. Weiner, Specific immune induction following 670 DNA-based immunization through in vivo transfection and activation of macrophages/antigen- 671 presenting cells, J Immunol, vol.160, pp.5707-5725, 1998.

J. Ulmer, R. Deck, C. Dewitt, J. Donnhly, and M. Liu, Generation of MHC class I-restricted 673

K. Vleugels, B. Ons, E. Vanrompay, D. Goddeeris, and B. , viral protein in muscle cells: antigen presentation by non- 674 muscle cells Evaluation of the persistence and 676 gene expression of an anti-Chlamydophila psittaci DNA vaccine in turkey muscle, Immunology BMC Vet Res, vol.89294, issue.677, pp.59-6718, 1996.

M. Tuomela, M. Malm, M. Wallen, I. Stanescu, K. Krohn et al., Biodistribution and general safety of a naked DNA plasmid, GTU??-MultiHIV, in a rat, using a quantitative PCR method, Vaccine, vol.23, issue.7, pp.890-896, 2005.
DOI : 10.1016/j.vaccine.2004.08.004

R. Winegar, J. Monforte, K. Suing, K. Ol, C. Rudd et al., Determination of 682 tissue distribution of an intramuscular plasmid vaccine using PCR and in situ DNA hybridization, p.683

H. Zhang, S. Sun, Y. Guo, Z. Chen, L. Huang et al., Tissue distribution of a Safety of a GM-CSF 687 adjuvant-plasmid DNA malaria vaccine, Gene Therapy, vol.978, pp.1011-1034, 1998.

S. Parker, F. Borellini, M. Wenk, P. Hobart, S. Hoffman et al., Plasmid DNA 689 malaria vaccine: tissue distribution and safety studies in mice and rabbits Definitive toxicology 692 and biodistribution study of a polyvalent DNA prime/protein boost human immunodeficiency virus 693 type 1 (HIV-1) vaccine in rabbits, Hum Gene Ther Vaccine, vol.6901024, pp.741-581225, 1999.

A. Mena, M. Andrew, and B. Coupar, Rapid dissemination of intramuscularly inoculated DNA vaccines, Immunology and Cell Biology, vol.68, issue.1, pp.87-96, 2001.
DOI : 10.1016/S0165-2427(99)00125-7

R. Gravier, D. Dory, M. Laurentie, S. Bougeard, R. Cariolet et al., In vivo tissue distribution and kinetics of a pseudorabies virus plasmid DNA vaccine after intramuscular injection in swine, Vaccine, vol.25, issue.39-40, pp.6930-6938, 2007.
DOI : 10.1016/j.vaccine.2007.07.001

M. Son, J. Choi, D. Lee, C. Kim, S. Choi et al., Pharmacokinetics and 700 biodistribution of a pGT2-VEGF plasmid DNA after administration in rats, J Cardiovasc Pharmacol, vol.70146, pp.699577-84, 2005.

K. Garver, C. Conway, D. Elliott, and G. Kurath, Analysis of DNA-vaccinated fish reveals 703 viral antigen in muscle, kidney and thymus, and transient histopathologic changes, Mar BiotechnolNY), vol.7047, pp.540-53, 2005.

N. Kim, S. Kwon, J. Lee, S. Kim, and T. Yoo, Protective effect of the DNA vaccine encoding the 706 major house dust mite allergens on allergic inflammation in the murine model of house dust mite 707 allergy, Clinical and Molecular Allergy, vol.4, issue.1, pp.4-708, 2006.
DOI : 10.1186/1476-7961-4-4

G. Armengol, L. Ruiz, S. Orduz, I. Sylvester, A. Ambali et al., The injection of plasmid DNA in mouse muscle results in 709 lifelong persistence of DNA, gene expression, and humoral response The safety and longevity of 711 DNA vaccines for fish, Mol Biotechnol Immunology, vol.2796, pp.307-320, 1999.

B. Kim, D. Lee, J. Choi, C. Kim, M. Son et al., In vivo kinetics and 713 biodistribution of a HIV-1 DNA vaccine after administration in mice, Arch Pharm Res, vol.26, pp.712493-712501, 2003.

S. Manam, B. Ledwith, A. Barnum, P. Troilo, C. Pauley et al., Plasmid DNA 715 vaccines: Tissue distribution and effects of DNA sequence, adjuvants and delivery method on 716 integration into host DNA Nasal absorption and 718 biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery, Intervirology Vaccine, vol.4310919, issue.719, pp.273-81, 2000.

C. Liu, M. Fan, Q. Xu, and Y. Li, Biodistribution and expression of targeted fusion anti-caries DNA vaccine pGJA-P/VAX in mice, The Journal of Gene Medicine, vol.23, issue.3, pp.298-305, 2008.
DOI : 10.1002/jgm.1138

C. Watkins, J. Hopkins, and G. Harkiss, Reporter gene expression in dendritic cells after gene gun administration of plasmid DNA, Vaccine, vol.23, issue.33, pp.4247-56, 2005.
DOI : 10.1016/j.vaccine.2005.03.023

Y. Jeon, Y. Choi, J. Kang, J. Chung, Y. Lee et al., In vivo monitoring of DNA vaccine gene expression using firefly luciferase as a naked DNA, Vaccine, vol.24, issue.16, pp.3057-62, 2006.
DOI : 10.1016/j.vaccine.2006.01.033

H. Garmory, K. Brown, and R. Titball, DNA vaccines: improving expression of antigens

J. Greenland, R. Geiben, S. Ghosh, W. Pastor, N. Letvin et al., Plasmid DNA vaccine-elicited Immune-mediated destruction of transfected muscle fibers 735 after direct gene transfer with antigen-expressing plasmid DNA, Genet Vaccines Ther Gene Ther, vol.11164, issue.2, pp.731-115, 1997.

M. Yokoyama, D. Hassett, J. Zhang, and J. Whitton, DNA immunization can stimulate florid local inflammation, and the antiviral immunity induced varies depending on injection site, Vaccine, vol.15, issue.5, pp.553-60, 1997.
DOI : 10.1016/S0264-410X(97)00213-2

P. Payette, R. Weeratna, M. Mccluskie, and H. Davis, Immune-mediated destruction of 740 transfected myocytes following DNA vaccination occurs via multiple mechanisms, Gene Therapy, vol.7418, pp.1395-400, 2001.

R. Geiben-lynn, J. Greenland, K. Frimpong-boateng, N. Van-rooijen, A. Hovav et al., CD4+ T lymphocytes mediate in vivo clearance of plasmid DNA vaccine antigen expression and potentiate CD8+ T-cell immune responses, Blood, vol.112, issue.12, pp.4585-90, 2008.
DOI : 10.1182/blood-2008-06-165803

M. Napirei, S. Wulf, D. Eulitz, H. Mannherz, and T. Kloeckl, Comparative characterization of rat deoxyribonuclease 1 (Dnase1) and murine deoxyribonuclease 1-like 3 (Dnase1l3), Biochemical Journal, vol.389, issue.2, pp.355-64, 2005.
DOI : 10.1042/BJ20042124

W. Baron, C. Pan, S. Spencer, A. Ryan, R. Lazarus et al., Cloning and 749 characterization of an actin-resistant DNase I-like endonuclease secreted by macrophages, Gene, vol.750215, pp.748291-301, 1998.

E. Kang, C. Kim, S. Kim, S. Im, S. Yang et al., In vivo kinetics and 752 biodistribution of HB-110, a novel HBV DNA vaccine, after administration in mice, Arch Pharm Res, vol.75330, pp.355-60, 2007.

J. Hisazumi, N. Kobayashi, M. Nishikawa, and Y. Takakura, Significant role of liver sinusoidal 755 endothelial cells in hepatic uptake and degradation of naked plasmid DNA after intravenous injection

F. Liu, L. Shollenberger, C. Conwell, X. Yuan, and L. Huang, Mechanism of naked DNA clearance after intravenous injection, The Journal of Gene Medicine, vol.11, issue.7, pp.613-622, 2007.
DOI : 10.1002/jgm.1054

W. Nichols, B. Ledwith, S. Manam, and P. Troilo, Potential DNA Vaccine Integration into Host Cell Genome, Annals of the New York Academy of Sciences, vol.63, issue.5, pp.30-39, 1995.
DOI : 10.1016/0264-410X(94)90077-9

K. Kang, S. Choi, J. Choi, D. Lee, C. Kim et al., Safety Evaluation of GX-12, a New HIV Therapeutic Vaccine: Investigation of Integration into the Host Genome and Expression in the Reproductive Organs, Intervirology, vol.46, issue.5, pp.270-276, 2003.
DOI : 10.1159/000073206

B. Ledwith, S. Manam, P. Troilo, A. Barnum, C. Pauley et al., Plasmid 765 DNA vaccines: assay for integration into host genomic DNA, -Din M, Yang L. Construction and evaluation of 767, pp.33-43, 2000.
DOI : 10.1159/000053993

T. Martin, S. Parker, R. Hedstrom, T. Le, S. Hoffman et al., Plasmid DNA malaria 770 vaccine: the potential for genomic integration after intramuscular injection, Hum Gene Ther, vol.77110, pp.759-68, 1999.

A. Vilalta, R. Mahajan, J. Hartikka, D. Rusalov, T. Martin et al., Poloxamer- 773 formulated plasmid DNA-based human cytomegalovirus vaccine: evaluation of plasmid DNA 774 biodistribution/persistence and integration, Plasmid DNA 776 vaccines: Investigation of integration into host cellular DNA following intramuscular injection in 777 mice, pp.7721143-50258, 2000.

Z. Wang, P. Troilo, X. Wang, T. Griffiths, S. Pacchione et al., Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation, Gene Therapy, vol.11, issue.8, pp.711-732, 2004.
DOI : 10.1038/sj.gt.3302213

U. The, D. Food, and . Adminitration, Guidance for Industry Considerations for Plasmid [134] The European Medicines Agency (EMA) Note for guidance: DNA vaccines non- 784 amplifiable in eukaryotic cells for veterinary use, p.98, 2000.